Select Page

News

Dr. Angela Genge, recipient of the Forbes Norris Award

Dr. Genge awarded the 2018 Forbes Norris Award A big congratulations to our inspiring director, Dr. Angela Genge, on receiving the Forbes Norris award at the ALS MND symposium in Glasgow, Scotland! She is recognized for her exceptional care and compassion towards ALS...

The first on the INTRAGO brain tumour trial in Canada

The first on the INTRAGO brain tumour trial in Canada Le premier de l'essai INTRAGO sur les tumeurs cérébrales au Canada Glioblastoma Multiforme is grade IV brain cancer that is very aggressive. There are currently no cure but research is advancing to find new ways to...

Eastern Neuromuscular Course Review

Eastern Neuromuscular Course Review (From https://www.mcgill.ca/neuro/events/eastern-neuromuscular-course-review) Dr. Nic Dupré of Laval University, Dr. Angela Genge of The Neuro and the members of our organizing committee are pleased to announce that...

Health Canada approves new drug to treat patients ALS

Health Canada approves new drug to treat patients with Amyotrophic Lateral Sclerosis (ALS) From CBC News: Ottawa has approved a drug to slow the progression of ALS. Edaravone is the first promising ALS drug to be approved in Canada in nearly 20...

Dr. Angela Genge – Neuro XXceptional

Dr. Angela Genge - Neuro XXceptional Neurologist Dr. Angela Genge is the Director of the ALS Clinic and the Clinical Research Unit at The Neuro. Dr. Genge has been awarded the YWCA Woman of Distinction Award in Science and Technology for her...

CJAD with Dr. Simon Ducharme

CJAD with Dr. Simon Ducharme Dr. Ducharme, a neuropsychiatrist at the Neuro was on CJAD to comment on clinical trials in dementia and Alzheimer’s. “Alzheimer’s is a complicated disease. Amyloid is one of the targets…We might need to treat on more than one...

Dr. Genge on CJAD Andrew Carter

For #ALSAwareness Month, Dr. Genge was on CJAD radio to discuss clinical trials and the need for new therapies in ALS. The month may be almost over, but the fight never ends for patients and their families.

Recent Facebook Posts

2 weeks ago

Clinical Research Unit at the Montreal Neurological Institute & Hospital

April is Parkinson's Disease Awareness Month. PD affects about 100,000 Canadians, and prevalence is 1.5 times higher among males than females and approximately 6,600 new cases are diagnosed each year.

In April, The Neuro is recognizing the outstanding medical staff and researchers at The Neuro working in PD and raising awareness about the services we offer our patients with this disease.

www.mcgill.ca/neuro/article/patient-stories-research-stories/parkinsons-awareness-month-2019
... See MoreSee Less

View on Facebook

(Fr suivant) April is Parkinson's Awareness Month. The Neuro is a leader in interdisciplinary care and research in Parkinson's Disease. Catch a glimpse of the Neuro's role below.

For more information on clinical trials in Movement Disorders or Parkinson's Disease, visit our website at cru.mcgill.ca **We have recruiting trials ongoing**

//

Avril est le mois de sensibilisation à la maladie de Parkinson. Le Neuro est un chef des soins et de la recherche interdisciplinaires dans la maladie de Parkinson. Voyez-vous le video pour apprendre au rôle du Neuro ci-dessous.

Pour plus d'informations sur les essais cliniques sur les troubles du mouvement ou la maladie de Parkinson, visitez notre site Web à l'adresse cru.mcgill.ca ** Des essais de recrutement sont en cours **Multidisciplinary care and cutting-edge research share space at The Neuro. To learn more visit: www.mcgill.ca/neuro/patients/clinics-and-health-care/m...
... See MoreSee Less

View on Facebook

4 weeks ago

Clinical Research Unit at the Montreal Neurological Institute & Hospital

(Fr suivant) As we continue to expand our program, we're excited to bring new #clinicaltrials and #therapies in to our patients with #haTTR #Amyloidosis, an ultra-rare genetic disease affecting multiple organ systems via the peripheral nerves.

Dr. Angela Genge: "There is currently an avalanche of new therapies in rare, neurologic disease...Patients who have never had therapies for their diseases now have the opportunity to be treated, and in some cases cured of the symptoms of the disease they carry."

The CRU is rising up to #meettheavalanche by promoting #geneticscreening in haTTR, in the hopes of giving patients the earliest access to treatment possible. Ongoing efforts encourage our colleagues throughout the province (and country) to screen for #raredisease.

Stay tuned for what's upcoming: cru.mcgill.ca

//

Alors que nous continuons à étendre notre programme, nous sommes ravis d'introduire de nouvelles #essaiscliniques et de nouvelles thérapies pour nos patients atteints d'#amyloidose #haTTR, une maladie génétique extrêmement rare qui affecte plusieurs systèmes d'organes via les nerfs périphériques.

Dre. Angela Genge: "Il existe actuellement une avalanche de nouveaux traitements dans les maladies neurologiques rares ... Les patients qui n’ont jamais bénéficié de traitements pour leurs maladies ont maintenant la possibilité d’être traités, et dans certains cas guéri des symptômes de la maladie qu'ils portent ".

L'URC se rapproche de #rencontrerlavalanche en promouvant le #dépistagegénétique dans haTTR, dans l’espoir de donner aux patients le plus rapidement possible un traitement. Les efforts en cours encouragent nos collègues de toute la province (et du pays) à dépister pour des #maladiesrares.

Restez à l'affût de ce qui vous attend: cru.mcgill.ca/fr/home-2/Témoignage sur l'AMYLOSE (OU AMYLOïDOSE) HÉRÉDITAIRE. Voir aussi le groupe de soutien canadien à madhattr.ca/
... See MoreSee Less

View on Facebook

1 month ago

Clinical Research Unit at the Montreal Neurological Institute & Hospital

(Fr suivant) This month The Neuro hosted a networking event that gave high school girls the chance to chat with #NeuroXXceptional women, including the CRU's own Kristiana Salmon. #womeninSTEM #careerbuilding

**Find out more about clinical trials by visiting our website cru.mcgill.ca **

//

Ce mois-ci, le Neuro a organisé un événement de réseautage qui a donné aux lycéennes la possibilité de discuter avec des femmes #NeuroXXceptional, y compris Kristiana Salmon, de la URC. #lesfemmesenSTIM #carrière

**En savoir plus sur les essaies cliniques en visitant notre site du web à cru.mcgill.ca **

The Neuro
Thank you to everyone who attended the #NeuroXXceptional Speed Networking event, an inspiring occasion when 60 female high-school students met with women leaders in science and medicine working at The Neuro.
... See MoreSee Less

View on Facebook